Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.

TerminatedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

February 28, 2019

Conditions
Obstructive Sleep Apnea
Trial Locations (8)

35706

Polyclinique Saint-Laurent, Rennes

69004

HCL - Croix-Rousse Hospital, Lyon

75000

Hopital Saint Antoine, Paris

Unknown

CH de Belfort, Belfort

Clinique Aguilera, Biarritz

Cabinet de Pneumologie, Blois

APHM, Marseille

Centre médical du sommeil, Metz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ResMed

INDUSTRY

NCT02930460 - Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy. | Biotech Hunter | Biotech Hunter